tiprankstipranks
Trending News
More News >
Windtree Therapeutics announces istaroxime Phase 2 study called SEISMiC B
PremiumThe FlyWindtree Therapeutics announces istaroxime Phase 2 study called SEISMiC B
18d ago
Windtree Therapeutics Raises $3.9M Through Note Agreements
Premium
Company Announcements
Windtree Therapeutics Raises $3.9M Through Note Agreements
23d ago
Windtree Therapeutics receives offer for preclinical oncology drug candidate
Premium
The Fly
Windtree Therapeutics receives offer for preclinical oncology drug candidate
23d ago
Windtree Therapeutics files to sell 42.17M shares of common stock for holders
PremiumThe FlyWindtree Therapeutics files to sell 42.17M shares of common stock for holders
2M ago
Windtree Therapeutics reports Q1 EPS ($4.63)
Premium
The Fly
Windtree Therapeutics reports Q1 EPS ($4.63)
2M ago
Windtree Therapeutics announces presentation highlighting istaroxime
Premium
The Fly
Windtree Therapeutics announces presentation highlighting istaroxime
2M ago
Windtree Therapeutics reports FY24 EPS ($104.35) vs. ($4,718.84) last year
PremiumThe FlyWindtree Therapeutics reports FY24 EPS ($104.35) vs. ($4,718.84) last year
3M ago
Windtree Therapeutics sees cash runway through April
Premium
The Fly
Windtree Therapeutics sees cash runway through April
3M ago
Windtree Therapeutics Delays Annual Report Filing
Premium
Company Announcements
Windtree Therapeutics Delays Annual Report Filing
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100